Epidemiological characteristics and trends of hepatitis C in Hubei Province from 2004 to 2018

WU Jing-tao; YU Chuan-hua; WANG Lei; HU Ying

doi:10.16462/j.cnki.zhjbkz.2020.04.016

Volume 24 Issue 4

Jun. 2020

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2020 > 24(4): 451-455

WU Jing-tao, YU Chuan-hua, WANG Lei, HU Ying. Epidemiological characteristics and trends of hepatitis C in Hubei Province from 2004 to 2018[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(4): 451-455. doi: 10.16462/j.cnki.zhjbkz.2020.04.016

Citation:

WU Jing-tao, YU Chuan-hua, WANG Lei, HU Ying. Epidemiological characteristics and trends of hepatitis C in Hubei Province from 2004 to 2018[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2020, 24(4): 451-455. doi: 10.16462/j.cnki.zhjbkz.2020.04.016

Citation:

PDF( 3739 KB)

Epidemiological characteristics and trends of hepatitis C in Hubei Province from 2004 to 2018

doi: 10.16462/j.cnki.zhjbkz.2020.04.016

1.
Global Health Institute, School of Health Science, Wuhan University, Wuhan 430071, China
2.
Institute of Infectious Disease Control and Prevention, Hubei Center for Disease Control and Prevention, Wuhan 430079, China

Funds: National Natural Science Foundation of China(81773552)

More Information

Corresponding author: HU Ying, E-mail:yingerhu2011@qq.com
Received Date: 2019-11-08
Rev Recd Date: 2020-01-20
Publish Date: 2020-04-10

Abstract

Abstract

Objective This study aims to know the incidence of hepatitis C and provide scientific opinions and suggestions for prevention and control of hepatitis C through analyzing the characteristics of hepatitis C in Hubei Province from 2004 to 2018. Methods Data of hepatitis C reported cases in the infectious disease report information management system were collected, analyzed and predicted by time series model. Results The incidence of hepatitis C continued to increase, from 1.82/10⁵ in 2004 to 18.51/10⁵ in 2018, with an average annual growth rate of 18.01%. The incidence of hepatitis C in all age groups increased from 2004 to 2018. In the same year, the incidence rate increased initially and then decreased with the elder age group. The peak was in 60-70 age group. Among the new diagnosed patients with hepatitis C, the top three occupations were farmers, housework and unemployed, retired people, accounting for more than 80% of the total. According to the prediction of time series model, the incidence of hepatitis C could exceed 24.88/10⁵ after 5 years if no effective control measures were taken. Conclusions The incidence of hepatitis C is still rising, and it has significant population and spatial distribution pattern. It is necessary to pay attention and take effective measures to reduce the incidence of new infections and diseases onset.
- Hepatitis C,
- Epidemiologic characteristic,
- Prediction

FullText(HTML)

References(16)

References

[1]	付睿, 陆长春, 刘慧.利巴韦林配伍PEG-IFNα-2a治疗对老年慢性丙肝患者血清可溶性Fas、FasL水平及T细胞亚群的影响[J].中国老年学杂志, 2019, 39(11): 2664-2667. DOI: 10.3969/j.issn.1005-9202.2019.11.032. Fu R, Lu CC, Liu H. Effects of ribavirin combined with PEG-IFNα-2a on serum soluble Fas, FasL levels and T cell subsets in elderly patients with chronic hepatitis C[J]. Chin J Geriatr, 2019, 39(11): 2664-2667. DOI: 10.3969/j.issn.1005-9202.2019.11.032.
[2]	陈若蝉, 刘振国, 范学工. DAA与HCC--丙肝治疗新时代的挑战[J].中国感染控制杂志, 2018, 17(5): 369-372. DOI: 10.3969/j.issn.1671-9638.2018.05.001. Chen RC, Liu ZG, Fan XG. DAA and HCC-Challeng einthene wear of hepatitis Ctreatment[J]. Chin J Infect Control, 2018, 17(5): 369-372. DOI: 10.3969/j.issn.1671-9638.2018.05.001.
[3]	常峰, 段承阿鑫, 金琇泽, 等.我国丙型肝炎治疗现状与相关医疗保障补偿机制分析及建议[J].中国药房, 2018, 29(2): 151-155. DOI: 10.6039/j.issn.1001-0408.2018.02.02. Chang F, Duan CAX, Jin YZ, et al. Analysis and suggestions on the situation ofhepatitis C treatment and related medical insurancecompensation mechanism in China[J]. China Pharmacy, 2018, 29(2): 151-155. DOI: 10.6039/j.issn.1001-0408.2018.02.02.
[4]	Das D, Pandya M. Recent advancement of direct-acting antiviral agents(DAAs)in hepatitis C therapy[J]. Mini Rev Med Chem, 2018, 18(7): 584-596. DOI: 10.2174/1389557517666170913111930.
[5]	Pradat P, Virlogeux V, Trépo E. Epidemiology and elimination of HCV-related liver disease[J]. Viruses, 2018, 10(10): 545. DOI: 10.3390/v10100545.
[6]	Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence[J]. Hepatology, 2013, 57(4): 1333-1342. DOI: 10.1002/hep.26141.
[7]	Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study[J]. Lancet Gastroenterol Hepatol, 2017, 2(3): 161-176. DOI: 10.1016/S2468-1253(16)30181-9.
[8]	中华人民共和国国家卫生和计划生育委员会. WS 213-2018丙型肝炎诊断[J].临床肝胆病杂志, 2018, 34(8): 1619-1621. DOI: 10.3969/j.issn.1001-5256.2018.08.006. National Health and Family Planning Commission of the People's Republic of China. WS 213-2018 diagnosis for hepatitis C[J]. J Clin Hepatol, 2018, 34(8): 1619-1621. DOI: 10.3969/j.issn.1001-5256.2018.08.006.
[9]	董旻晔, 肖煜吟, 贾芷莹, 等.基于时间序列模型的全国监测地区婴儿死亡率预测分析[J].中国妇幼保健, 2019, 34(14): 3156-3159. DOI: 10.7620/zgfybj.j.issn.1001-4411.2019.14.04. Dong MY, Xiao YY, Jia ZY, et al. Prediction of infant mortality in national surveillance areas based on time series model[J]. Maternal and Child Health Care of China, 2019, 34(14): 3156-3159. DOI: 10.7620/zgfybj.j.issn.1001-4411.2019.14.04.
[10]	宇方, 陈婷婷, 唐倩, 等.利用ARIMA模型对医院感染现患率进行预测[J].中华医院感染学杂志, 2019, 29(8): 1246-1250. DOI: 10.11816/cn.ni.2019-184032. Yu F, Chen TT, Tang Q, et al. Prediction of prevalence rate of nosocomial infection by using ARIMA model[J]. Chin J Nosocomiol, 2019, 29(8): 1246-1250. DOI: 10.11816/cn.ni.2019-184032.
[11]	刘刚, 唐宋, 孙文杰.时间序列分析法在香港结核病预测中的应用[J].中国卫生统计, 2012, 29(2): 226-228. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgwstj201202021 Liu G, Tang S, Sun WJ. Application of time series analysis in tuberculosis prediction in Hong Kong[J]. Chin J Health Stati, 2012, 29(2): 226-228. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgwstj201202021
[12]	Ansaldi F. Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy[J]. World J Gastroenterol, 2014, 20(29): 9633. DOI: 10.3748/wjg.v20.i29.9633.
[13]	裴晓迪, 刘伦皓, 刘莉, 等. 2014年四川省丙型病毒性肝炎病例报告数据质量核查结果分析[J].职业卫生与病伤, 2018, 33(6): 348-351. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zywsybs201806007 Pei XD, Liu LH, Liu L, et al. The results of quality check of case reporting data ofhepatitis C in Sichuan in 2014[J]. Occupational Health and Damage, 2018, 33(6): 348-351. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zywsybs201806007
[14]	赵亚栋, 屠爱霞, 王晓蕊, 等.甘肃省2004-2018年丙型肝炎流行特征[J].中华疾病控制杂志, 2019, 23(8): 922-926. DOI: 10.16462/j.cnki.zhjbkz.2019.08.008. Zhao YD, Tu AX, Wang XR, et al. Epidemiologic characteristics of hepatitis C in Gansu Province from 2004 to 2018[J]. Chin J Dis Control Prev, 2019, 23(8): 922-926. DOI: 10.16462/j.cnki.zhjbkz.2019.08.008.
[15]	陈锁玉, 李世福, 蒋丹兰, 等. 2005-2017年玉溪市丙型病毒性肝炎流行特征与趋势分析[J].现代预防医学, 2019, 46(17): 3217-3220. http://www.cnki.com.cn/Article/CJFDTotal-XDYF201917032.htm Chen SY, Li SF, Jiang DL, et al. Epidemiological trends and characteristics of hepatitis C in Yuxi, 2005-2017[J]. Modern Prevent Med, 2019, 46(17): 3217-3220. http://www.cnki.com.cn/Article/CJFDTotal-XDYF201917032.htm
[16]	赵庆龙, 吕波, 李美娜, 等. 1997-2012年吉林省丙型病毒性肝炎流行病学特征分析[J].中华疾病控制杂志, 2014, 18(7): 594-596. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jbkzzz201407003 Zhao QL, Lv B, Li MN, et al. Epidemic situation of hepatitis C in Jilin Province, 1997-2012[J]. Chin J Dis Control Prev, 2014, 18(7): 594-596. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jbkzzz201407003